Book Description:
Realizing the impact of smoking on the human beings, the US Public Health Service updated its 2000 Guidelines for Treating Tobacco Use and Dependence in 2008 and the WHO released the MPOWER package. Both guidelines aim to counter the tobacco epidemic and reduce its deadly toll. Smoking is a leading preventable cause of mortality in the U.S. and worldwide. Tobacco use is growing fastest in the low income countries due to steady population growth coupled with tobacco industry targeting, ensuing that millions of people get fatally addicted every year. The data made available through litigation has shown that the tobacco industry has invested a tremendous amount of time and money studying young adult smoking patterns. This book will illuminate these various aspects of smoking addiction. (Imprint: Novinka)

We’ve partnered with Copyright Clearance Center to make it easy for you to request permissions to reuse Nova content.
For more information, click here or click the "Get Permission" button below to link directly to this book on Copyright Clearance Center's website.

Table of Contents:
Preface

1. Neurobiology of nicotine dependence pp.1-2

2. Pharmacotherapy pp.3-4

3. Nicotine Replacement Therapy (NRT)pp.5-6

4. Nicotine gum pp.7-10

5. Transdermal nicotine patch pp.11-12

6. Nicotine lozenge pp.13-14

7. Nicotine nasal spray pp.15-18

8. Nicotine inhaler pp.19-20

9. Status and newer recommendations for NRT pp.21-24

10. Bupropion pp.25-26

11. Varenicline pp.27-28

12. Clonidine pp.29-30

13. Nortriptyline pp.31-32

14. Nicotinic or Non-Nicotinic Therapies Under Investigation
Nicotine vaccines pp.33-34

15. Rimonabant pp.35-36

16. Mecamylamine pp.37-38

17. Inhibitors of Nicotine metabolism pp.39-40

18. Opioid antagonists pp.41-42

19. Antidepressants pp.43-44

20. GABAergic agents pp.45-46

21. Drug Therapy in Pregnant Females pp.47-48

22. Critical issues of pharmacotherapy pp.49-50

References pp.51-64

Index pp.65-69